CSL
Senior Director, Head of Translational Research Hematology & Cardiovascular, Renal based in Switzerland leading a translational research group within CSL’s R&D organisation. The role focuses on advancing therapies for cardiovascular, renal and haematological diseases by bridging scientific discovery and clinical application and shaping translational strategy across preclinical and clinical efforts. It is a strategic leadership position within the Translational and Data Science leadership team.
Headquarters
Melbourne, Victoria, Australia
Company Size
10001+ employees
Founded
1916
CSL is a leading global biotechnology company dedicated to creating lifesaving medicines. With a portfolio that includes therapies for rare diseases, immune deficiencies, and vaccines for influenza, CSL's mission is rooted in innovation and public health. The organization comprises three distinct businesses: CSL Behring, focused on plasma-derived therapies; CSL Seqirus, specializing in influenza vaccines; and CSL Vifor, addressing iron deficiency and nephrology. Since its founding in 1916, CSL has been committed to ensuring access to essential treatments for patients in over 100 countries.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for CSL.
CSL didn’t post a salary, so this is our estimate from similar listings.
Postdoctoral Fellow in Translational Neuroscience
Merck & Co., Inc.
Director, Translational Science Lead
JobAps
VP, Preclinical & Translational Medicine
Eleventx
Principal Scientist, Kidney Disease Research Expert - In Vitro, CVRI
City of Duncan, Oklahoma
Associated Director Translational Research CVR&H
CSL Behring Australia
Director of Preclinical & Clinical Science
Wellfound